SYNOPSYS INC
For the period ended Apr 30, 2026. Filed May 27, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2026 · Filed May 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
|---|
(c) Stock Repurchases
In March 2026, we entered into an accelerated stock repurchase agreement (the March 2026 ASR) to repurchase anaggregate of $250.0 million of our common stock. Pursuant to the March 2026 ASR, we made a prepayment of $250.0 million to receive initial deliveries of shares valued at $212.5 million. The remaining share repurchase of $37.5 million will be completed no later than June 1, 2026.
During the three months ended April 30, 2026, we also repurchased on the open market approximately 126.7 thousand shares of our common stock pursuant to the Program, at an average price of $394.78 per share for an aggregate purchase price of $50.0 million.
The table below sets forth information regarding our repurchases of our common stock during the three months ended April 30, 2026:
| Period | Total numberof sharespurchased(1) | Averageprice paidper share(1) | Totalnumber ofsharespurchasedas part ofpubliclyannouncedprograms(1) | Maximum approximate dollarvalue of sharesthat may yet bepurchasedunder theprograms(2) |
|---|---|---|---|---|
| February 1, 2026 through February 28, 2026 | — | $— | — | $2,000,000,000 |
| March 1, 2026 through March 31, 2026 | 605,380 | $411.02 | 605,380 | $1,713,677,459 |
| April 1, 2026 through April 30, 2026 | 34,560 | $395.76 | 34,560 | $1,700,000,097 |
| Total | 639,940 | $410.19 | 639,940 | $1,700,000,097 |
(1)Amounts are calculated based on the settlement date.
(2) In fiscal 2022, Our Board of Directors (the Board) approved and publicly announced a stock repurchase program (the Program) with authorization to purchaseup to$1.5 billion of our common stock. In February 2026, the Board approved a replenishment of the Program with authorization to purchase up to $2.0 billion of our common stock. As of April 30, 2026, $1.7 billion remained available for future repurchases under the Program.
See Note 14. Stock Repurchase Programof the Notes to Condensed Consolidated Financial Statements in this Quarterly Report for more information on the Program.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.